---
title: "Blue Sail Medical Co., Ltd. (002382.SZ)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/002382.SZ.md"
symbol: "002382.SZ"
name: "Blue Sail Medical Co., Ltd."
industry: "Health Care Supplies"
datetime: "2026-05-19T19:42:24.753Z"
locales:
  - [en](https://longbridge.com/en/quote/002382.SZ.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/002382.SZ.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/002382.SZ.md)
---

# Blue Sail Medical Co., Ltd. (002382.SZ)

## Company Overview

Blue Sail Medical Co.,Ltd. operates as a medical device company in China and internationally. It operates through Health Protection Division; Cardiovascular and Cerebrovascular Department; and Emergency Rescue Division segments. The company offers cardiovascular and cerebrovascular products comprising drug-eluting stents and balloons, conventional balloons, and transcatheter aortic valve replacement systems; and disposable health protection gloves consisting of disposable nitrile, PVC, latex, and TPE/CPE gloves, as well as polyurethane gloves for use in medical examinations, food processing, industrial labor protection, daily protection, and other applications.

| Item | Detail |
|------|--------|
| Industry | Health Care Supplies |
| Exchange | CN Market |
| Website | [www.bluesail.cn](https://www.bluesail.cn) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: D
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-19T04:30:08.000Z

**Overall: D (0.67)**

**Industry**: Health Care Supplies

| Metric | Value |
|--------|-------|
| Industry Ranking | 34 / 40 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: D

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -7.01% |  |
| Net Profit YoY | -211.97% |  |
| P/B Ratio | 0.97 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 6691330091.57 |  |
| Revenue | 5830828653.63 |  |

#### Multi Score Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -10.96% | D |
| Profit Margin | -14.41% | D |
| Gross Margin | 25.02% | C |
| Revenue YoY | -7.01% | D |
| Net Profit YoY | -211.97% | E |
| Total Assets YoY | -6.97% | D |
| Net Assets YoY | -6.86% | D |
| Cash Flow Margin | -37.65% | E |
| OCF YoY | -7.01% | D |
| Turnover | 0.35 | D |
| Gearing Ratio | 41.62% | C |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Blue Sail Medical Co., Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-7.01%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-211.97%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "0.97",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "6691330091.57",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "5830828653.63",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-10.96%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "-14.41%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "25.02%",
          "rating": "C"
        },
        {
          "name": "Revenue YoY",
          "value": "-7.01%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "-211.97%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "-6.97%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "-6.86%",
          "rating": "D"
        },
        {
          "name": "Cash Flow Margin",
          "value": "-37.65%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "-7.01%",
          "rating": "D"
        },
        {
          "name": "Turnover",
          "value": "0.35",
          "rating": "D"
        },
        {
          "name": "Gearing Ratio",
          "value": "41.62%",
          "rating": "C"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -7.94 | 34/40 | - | - | - |
| PB | 0.97 | 2/40 | 0.86 | 0.76 | 0.72 |
| PS (TTM) | 1.14 | 1/40 | 1.14 | 1.00 | 0.94 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Snibe (300832.SZ) | A | D | C | A | C | B |
| 02 | Winner Medical (300888.SZ) | B | B | B | B | B | B |
| 03 | Fuerjia (301371.SZ) | B | C | D | A | B | B |
| 04 | MTM (688029.SH) | B | B | B | A | B | B |
| 05 | Endovastec (688016.SH) | A | B | D | A | B | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/002382.SZ/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/002382.SZ/norm.md)
- [Related News](https://longbridge.com/en/quote/002382.SZ/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/002382.SZ/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**